Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with a suspected breast cancer diagnosis who are scheduled to have a biopsy or surgery to remove tissue, following assessment by a specialist according to their hospital's guidelines
- Cases where there is extra (leftover) fresh tumour tissue available after the procedure
- People who are able and willing to sign a written consent form agreeing to take part
Who may not be able to join:
- People who are not able to give their informed consent to participate
- People who have already started medical treatment for breast cancer (note: this does not include non-biomedical treatments such as herbal medicines)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Oliver Henke, MD, Section Global Health, University Hospital Bonn
Phone: +49 (0) 228 287 51521
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Non-inferiority of nanopore-based biomarker evaluation; Feasibility; Turnaround time
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.